inflammatory bowel disease

Jul 22, 2021

ProciseDx Enters Markets for Inflammation, Medication Monitoring With Five-Minute POC Instrument
Premium

Jun 15, 2021

Norwegian Firm Genetic Analysis Awarded $1.9M to Develop Microbiome Test for IBD Treatment

May 6, 2021

Coral Genomics Bets on Diverse Data to Advance Precision Medicine for Autoimmune Disease
Premium

Mar 12, 2021

Prometheus Biosciences Prices Upsized $190M IPO

Oct 22, 2019

KSL Biomedical to Commercialize PredictImmune IBD Test in North America

Oct 4, 2019

Prometheus Biosciences, Takeda Pharmaceutical to Codevelop Targeted Therapies, CDx for IBD

Oct 3, 2019

After Spin Off From Prometheus, ProciseDx Targets POC Tests for Inflammatory, Autoimmune Conditions
Premium

Jul 30, 2019

PredictImmune Closes £10M Series B Financing Round

Jul 12, 2019

Nestlé Health Science Sells Prometheus Laboratories, Layoffs Anticipated

Jun 28, 2019

Bühlmann Labs IBD Assay FDA Cleared

Jun 27, 2019

New Biomarker of Intestinal Permeability Could Lead to Dx for Gut Function
Premium

Mar 15, 2019

Luxia Scientific Inks Microbiome Test Distribution Deal with Life Genomics

Jan 24, 2019

Gemelli Biotech, Advanced Medical German Ink Distribution Deal for IBS Test in Middle East, Northern Africa

Dec 13, 2018

PredictImmune Wins £100K Grant for Study of IBD Prognostic

Oct 25, 2018

Inova Receives FDA Clearance for Fecal Extraction Device

Jun 14, 2018

Bühlmann Labs Gets FDA Clearance for Calprotectin Inflammatory IBD Assay

Jan 3, 2018

Inova Diagnostics Gets FDA Clearance for Quanta Flash Calprotectin

Jun 8, 2017

Seattle Children's Trial Aims to ID Immune Pathways in IBD, Graft Versus Host Disease
Premium

May 19, 2017

IQuity Receives $2.35M in Round of Seed Funding, Set to Launch First RNA-Based Diagnostic Test
Premium

Apr 7, 2017

IS-Diagnostics Readying PCR-Based Microbiota Characterization Kit to Diagnose IBD
Premium